1. Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial
by Peter Dreger, Hartmut Döhner, Fabienne McClanahan, Raymonde Busch, Matthias Ritgen, Hildegard Greinix, Anna-Maria Fink, Wolfgang Knauf, Michael Stadler, Michael Pfreundschuh, Ulrich Dührsen, Günter Brittinger, Manfred Hensel, Johannes Schetelig, Dirk Winkler, Andreas Bühler, Michael Kneba, Norbert Schmitz, Michael Hallek, and Stephan Stilgenbauer
Blood
Volume 119(21):
May 24, 2012
©2012 by American Society of Hematology

2. Consort diagram. Consort diagram.
Peter Dreger et al. Blood 2012;119:
©2012 by American Society of Hematology

3. PFS and OS of CLL3 patients.
PFS and OS of CLL3 patients. PFS (left) and OS (right) of all 169 evaluable patients registered for CLL3 (A-B) according to IGHV status (C-D) and FISH karyotype (hierarchical model; E-F).
Peter Dreger et al. Blood 2012;119:
©2012 by American Society of Hematology

4. Patient analyses.
Patient analyses. PFS (A), TTRT (B), OS (C), and NRM (D) of 110 CLL3 patients (green) and 126 CLL8(FCR) patients (blue) matched for age and absence of pretreatment.
Peter Dreger et al. Blood 2012;119:
©2012 by American Society of Hematology